Clinical Trial Update: A Phase II Study of Abraxane Gemcitabine Combination in Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase II study evaluating the combination of Abraxane with gemcitabine for metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Gemzar (gemcitabine)

Snippet

Sponsor: Fudan University | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED